Видео с ютуба Fred Lublin

Hope for Progressive MS 2012 by Fred Lublin, MD

A Labeling Indication of SPMS Can Treat More Patients

Defining active Secondary Progressive Multiple Sclerosis

MyCounterpane One On One With Dr. Fred Lublin

Determining SPMS as Biological Instead of Classification

Fred Lublin, MD: Current Challenges in MS

Treating the Whole Disease - National MS Society

Fred Lublin, MD: The Primary Care Partnership in Multiple Sclerosis

The challenge of treating progressive MS - Fred Lublin, MD - Medpage Today

Fred Lublin, MD: Beginning to Treat Progressive Multiple Sclerosis

Fred Lublin, MD: Biomarkers in MS

Multiple Sclerosis - Fred D. Lublin, MD

Fred Lublin, MD, Examines Research and Key Takeaways from ECTRIMS 2013

Fred Lublin, MD, discusses the vital information that’s needed to optimally characterize MS

Secondary Progressive Multiple Sclerosis: Managed Care Implications

Dr. Fred D. Lublin Invites You to the 3rd Annual International Congress on the Future of Neurology®

Clinical Features of Secondary Progressive Multiple Sclerosis

How Long Do I Stay on Therapy? - National MS Society

Questions and Answers with Dr. Fred Lublin at ACTRIMS 2016

2011 The Promise of Future Therapies by Fred D. Lublin, MD